Basel Medical Group Price to Book Ratio 1971-1970 | BMGL
Historical price to book ratio values for Basel Medical Group (BMGL) over the last 10 years. The current price to book ratio for Basel Medical Group as of May 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Basel Medical Group Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-05-23 | 1.37 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.025B | $0.000B |
Basel Medical Group Ltd is a clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic procedures as well as neurosurgical treatments. Basel Medical Group Ltd is based in Singapore. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $132.070B | 24.77 |
Elevance Health (ELV) | United States | $84.109B | 10.85 |
CVS Health (CVS) | United States | $76.951B | 9.56 |
Cencora (COR) | United States | $56.664B | 19.71 |
DiDi Global (DIDIY) | China | $22.591B | 34.29 |
Natera (NTRA) | United States | $20.935B | 0.00 |
BioMerieux (BMXMF) | France | $15.355B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.529B | 0.00 |
Solventum (SOLV) | United States | $12.251B | 12.97 |
CochLear (CHEOY) | Australia | $11.298B | 0.00 |
Revvity (RVTY) | United States | $10.529B | 18.12 |
ICON (ICLR) | Ireland | $10.336B | 9.61 |
Viatris (VTRS) | United States | $9.730B | 3.34 |
Doximity (DOCS) | United States | $9.525B | 44.37 |
Avantor (AVTR) | United States | $8.647B | 12.56 |
HealthEquity (HQY) | United States | $8.564B | 42.13 |
Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
Sonic Healthcare (SKHHY) | Australia | $8.176B | 0.00 |
Charles River Laboratories (CRL) | United States | $6.716B | 13.16 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
BrightSpring Health Services (BTSG) | United States | $4.048B | 37.47 |
Bausch + Lomb (BLCO) | Canada | $3.990B | 23.52 |
Sotera Health (SHC) | United States | $3.452B | 19.61 |
Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
Alignment Healthcare (ALHC) | United States | $2.865B | 0.00 |
Concentras Parent (CON) | United States | $2.710B | 15.66 |
Organon (OGN) | United States | $2.259B | 2.40 |
Ardent Health Partners (ARDT) | United States | $2.091B | 8.91 |
GeneDx Holdings (WGS) | United States | $2.043B | 78.68 |
Premier (PINC) | United States | $1.899B | 14.41 |
Progyny (PGNY) | United States | $1.759B | 38.72 |
PACS (PACS) | United States | $1.497B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.336B | 26.71 |
Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.944B | 14.74 |
Agilon Health (AGL) | United States | $0.919B | 0.00 |
Nutex Health (NUTX) | United States | $0.890B | 13.45 |
AMN Healthcare Services Inc (AMN) | United States | $0.795B | 7.44 |
QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
Embecta (EMBC) | United States | $0.626B | 4.22 |
InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
LifeMD (LFMD) | United States | $0.524B | 0.00 |
Enhabit (EHAB) | United States | $0.518B | 42.58 |
Auna S.A (AUNA) | Luxembourg | $0.492B | 11.08 |
SBC Medicals (SBC) | United States | $0.471B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
Oncology Institute (TOI) | United States | $0.228B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.215B | 0.00 |
Beauty Health (SKIN) | United States | $0.202B | 0.00 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
DocGo (DCGO) | United States | $0.137B | 22.33 |
OncoCyte (OCX) | United States | $0.096B | 0.00 |
So-Young (SY) | China | $0.087B | 0.00 |
Sera Prognostics (SERA) | United States | $0.066B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
Biodesix (BDSX) | United States | $0.050B | 0.00 |
Pheton Holdings (PTHL) | China | $0.043B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
ModivCare (MODV) | United States | $0.013B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |